Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer

Summary

This phase II trial is studying how well fenretinide works in treating patients with biochemically (rising PSA level) recurrent hormone-naïve (no previous hormone therapy) prostate cancer. Drugs used in chemotherapy, such as fenretinide, work in different ways to stop tumor cells from dividing so they stop growing or die

Timeline

Start

2004-06

Primary completion

2009-01

Completion

2009-01

Drugs

Indications